Company Profiles

driven by the PitchBook Platform

Apertus Pharmaceuticals

Apertus Pharmaceuticals
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$170K LATEST DEAL AMOUNT
1 INVESTORS
Description

Provider of pharmaceutical manufacturing and analytical services. The company provides controlled substance APIs, non controlled substance APIs and intellectual property to the pharmaceutical market.

Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 331 Consort Drive
  • Ballwin, MO 63011
  • United States

+1 (866) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Apertus Pharmaceuticals’s full profile, request a free trial.

Apertus Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Grant 01-Jan-2011 $170K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Apertus Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioGenerator Not-For-Profit Venture Capital 000 0000 000000 0

Apertus Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Rick Ryan Ph.D Chief Executive Officer
David Gindelberger Chief Scientific Officer
Denise Heinz Manager, Operations